Diabetes: Secondary Complications, Regulation and Innovation

-

Join your peers at the only conference dedicated to the leading causes of mortality and morbidity in diabetes, this autumn, in London. Our distinguished faculty unite the fields of pharmacology, nanotechnology and clinical medicine to target atherosclerosis, endothelial inflammation and end-stage renal disease.

SMi's unique program brings together the latest research from those at the forefront of attenuating the complications arising from hyperglycaemia, dyslipidaemia, and angiopathy.

“This conference is an excellent one stop shop to up-skill on current issues in diabetes therapy. I’m happy to chair what will no doubt be a very stimulating session.” – Phil Ambery, Medical Director, GlaxoSmithKline

Key Reasons to Attend:
• Receive clinical updates on novel GLP1 receptor agonists, and SLGT2 and DPP-4 inhibitors
• Utilise biomarkers and imaging for the development of novel therapies for diabetes
• Discuss new therapeutic targets to reduce hypertension, hyperkalaemia and endothelial inflammation in diabetes
• Remain abreast of new EU and FDA guidelines on clinical trials on risk-benefit assessment
• Capitalise on the effects of targeting RAAS, CCN2 and CCN3 inhibitors
• Review clinical results from the DEMAND study

Key Speakers Include:
• James F. List, Vice President and Full Development Lead, Dapagliflozin, Bristol-Myers Squibb
• John Wilding, Professor of Medicine & Honorary Consultant Physician, Head of Department of Obesity and Endocrinology, University of Liverpool Hospital
• Martin Siman, Director, Design and Interpretation Centre of Excellence, AstraZeneca
• Philip Ambery, Director, Clinical Development, GlaxoSmithKline
• Sandra Souza, Team Lead, Molecular Biomarkers, PPDM , Merck Sharp & Dohme

Diabetes: Secondary Complications, Regulation and Innovation, promises to be a unique platform for networking, problem solving and learning from timely case studies. This really is a unique event not to be missed.

Click here to find out more and/or book your place.

Location:
Marriott Hotel, Regents Park
UK
UK


Organizer: SMi Group Ltd

1 Oct 2013

UPCOMING FEATURED EVENTS 1 2 Next 
PepTalk: The Protein Science Week19 Jan 2015 Read
SLAS20157 Feb 2015 Read
Electronic Data in Clinical Trials24 Feb 2015 Read
Pittcon Conference and Expo 20158 Mar 2015 Read
Biotherapeutics Analytical Summit9 Mar 2015 Read
Extracellular Biomarkers Summit16 Mar 2015 Read
Targeting Mitochondrial Dysfunction & Toxicity19 Mar 2015 Read
AACR (American Association for Cancer Research)18 Apr 2015 Read


ALL UPCOMING EVENTS
1 2 Next 
Revolutionizing Next-Generation Sequencing: Tools and Technologies15 Jan 2015 Read
PepTalk: The Protein Science Week19 Jan 2015 Read
Pharmaceutical Microbiology21 Jan 2015 Read
MedLab26 Jan 2015 Read
7th Annual Pre-Filled Syringes Conference and Exhibition28 Jan 2015 Read
The Biologics Congress2 Feb 2015 Read
Biophysical Society 59th Annual Meeting7 Feb 2015 Read
SLAS20157 Feb 2015 Read
Parallel Trade9 Feb 2015 Read
Advances and Progress in Drug Design 201516 Feb 2015 Read
RNA Therapeutics16 Feb 2015 Read
Electronic Data in Clinical Trials24 Feb 2015 Read
Cell Culture World Congress24 Feb 2015 Read
13th International Congress on Targeted Anticancer Therapies2 Mar 2015 Read
Pittcon Conference and Expo 20158 Mar 2015 Read
Biotherapeutics Analytical Summit9 Mar 2015 Read
Extracellular Biomarkers Summit16 Mar 2015 Read
MEDLAB Asia Pacific18 Mar 2015 Read
Targeting Mitochondrial Dysfunction & Toxicity19 Mar 2015 Read
ACS National Meeting and Exposition22 Mar 2015 Read
Arablab23 Mar 2015 Read
Sensors in Medicine 201524 Mar 2015 Read
Paediatric Clinical Trials25 Mar 2015 Read
Superbugs and Superdrugs25 Mar 2015 Read
Experimental Biology28 Mar 2015 Read
World Vaccine Congress US7 Apr 2015 Read
Asthma & COPD13 Apr 2015 Read
Analytica Vietnam15 Apr 2015 Read
AACR (American Association for Cancer Research)18 Apr 2015 Read
Adaptive Designs in Clinical Trials20 Apr 2015 Read